Mumbai Pharma Strike: E-Pharma Companies, Chemists Slam Aggressive Pricing Strategies | WION
Why It Matters
The protest could force stricter regulation of online drug sales, reshaping India’s pharmaceutical distribution and protecting small retailers while safeguarding patient safety.
Key Takeaways
- •Nationwide chemist strike protests e‑pharmacy pricing and unregulated sales.
- •AIOCD claims online platforms sell prescription drugs without verification.
- •Deep discounting by e‑pharmacies threatens profitability of small retailers.
- •Government assures essential medicines remain available through hospitals and Jan Aushadhi.
- •Approximately 80% of private pharmacies shut, causing patient inconvenience.
Summary
India’s chemists and druggists have launched a one‑day, nationwide bandh, shutting roughly 80% of private medical stores to protest the rise of e‑pharmacy platforms and their aggressive discounting tactics.
The All India Organization of Chemists and Druggists (AIOCD) alleges that many online retailers dispense prescription‑only medicines, including antibiotics and scheduled drugs, without proper verification, eroding public‑health safeguards and undercutting brick‑and‑mortar margins. Reports suggest 120,000‑150,000 pharmacists and distributors are participating, while state associations in at least 12 regions have opted out.
On the ground in Mumbai’s eastern suburbs, correspondent Disha Yadav observed the iconic Metro Chemist closed, yet government officials emphasized that hospital pharmacies, Jan Aushadhi Kendras and emergency outlets will stay open, ensuring critical drug supply.
The strike highlights growing tension between traditional pharmacy networks and digital health players, signaling potential regulatory scrutiny and prompting e‑pharmacies to reassess pricing models to avoid further market disruption.
Comments
Want to join the conversation?
Loading comments...